Registered South Africa · SAHPRA

SPERSATEAR

HYPROMELLOSE

N/15.4/22 sensory organs INN generic

What it does

Hypromellose is a substance that helps to keep the eyes moist and can be used to soothe irritation.

Commonly used for: dry eyes (keratoconjunctivitis sicca), eye irritation

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
N/15.4/22
Registration date
1984/02/17
Expiry date
-
Status
Registered
Active ingredient
HYPROMELLOSE
Dosage form
-
Strength
-
Pack size
-
Therapeutic class
-
ATC class (WHO)
S01KA - Viscoelastic substances
Drug group
SENSORY ORGANS
RxNorm RxCUI
27334
Manufacturer / MAH
-
Applicant / LTR
Adcock Ingram Limited
Country of origin
-

Source: South African Health Products Regulatory Authority · fetched 2026-04-15 21:12:04 · updated 2026-09-20 04:00:08

Disclaimer: This information is sourced from South African Health Products Regulatory Authority (South Africa). Always consult a qualified healthcare professional before using any medication.

About this medicine

Hypromellose is a substance that helps to keep the eyes moist and can be used to soothe irritation.

What it treats

  • dry eyes (keratoconjunctivitis sicca)
  • eye irritation

How it works

It forms a protective layer over the eye, which helps to retain moisture and relieve discomfort.

Who it's for

This medication is suitable for anyone experiencing dry or irritated eyes.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: Hypromellose

BNF-referenced

Hypromellose is a semisynthetic polymer derived from cellulose, primarily used as an ocular lubricant in the management of dry eye conditions. It acts by forming a protective layer over the eye surface, providing moisture and relief from irritation, thereby improving comfort and protecting the corneal epithelium.

Indications

  • Dry eye conditions
  • Tear deficiency
  • Keratoconjunctivitis sicca

Dosage

Children: Apply as required, typically in the form of eye drops.

Adults: Apply as required, typically in the form of eye drops.

Mechanism of action

Hypromellose acts by forming a viscous gel upon contact with the ocular surface, which helps to retain moisture and protect against irritants. This gel-like property enhances the stability of the tear film and reduces evaporation, thereby alleviating symptoms associated with dry eye conditions.

Pharmacodynamics

The pharmacodynamic effects of hypromellose are primarily related to its ability to mimic natural tears, providing lubrication to the ocular surface. This lubrication reduces friction during blinking and maintains corneal hydration, which is critical for ocular comfort and health. Its high viscosity also contributes to prolonged retention time on the eye surface.

Pharmacokinetics

Hypromellose is administered topically as eye drops and is not significantly absorbed systemically. The retention time of hypromellose on the ocular surface is enhanced due to its viscosity, allowing for extended relief of dry eye symptoms. The elimination of hypromellose occurs primarily through drainage from the eye and dilution by the natural tear fluid.

Adverse effects

  • Temporary visual disturbance
  • Eye irritation

Precautions

  • Should not be used during contact lens wear
  • Use with caution in patients with known hypersensitivity to any component of the formulation

Pregnancy

Hypromellose is generally considered safe for use during pregnancy. However, it should be used only if clearly needed and after consulting a healthcare provider.

Breast-feeding

Hypromellose is unlikely to affect breastfed infants when used as directed, but consultation with a healthcare provider is advisable.

Storage

Store in a cool, dry place away from direct sunlight. Once opened, use within a specified period as indicated on the packaging.

Formulations

  • {'name': 'Teardew', 'concentration': '0.3%', 'form': 'eye drops', 'volume': '10 ml'}
  • {'name': 'Xailin Hydrate', 'concentration': '0.3%', 'form': 'eye drops', 'volume': '10 ml'}
  • {'name': 'AacuLose', 'concentration': '0.3%', 'form': 'eye drops', 'volume': '10 ml'}
  • {'name': 'Artelac', 'concentration': '0.32%', 'form': 'eye drops', 'volume': '10 ml'}
  • {'name': 'Lacrilube', 'concentration': '2 mg/g', 'form': 'eye ointment', 'volume': '3.5 g'}
  • {'name': 'Celluvisc', 'concentration': '1%', 'form': 'eye drops', 'volume': '0.4 ml unit dose'}
BNF 85 (British National Formulary) p.1302 BNF for Children 2019-2020 p.718 PubChem / pathway

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.